Influence of blood pressure on pneumonia risk: Epidemiological association and Mendelian randomisation in the UK Biobank

Objectives: To determine whether elevated blood pressure influences risk for respiratory infection. Design: Prospective, population-based epidemiological and Mendelian randomisation studies. Setting: UK Biobank. Participants: 377,143 self-identified British descent (54% women; median age 58 years) participants in the UK Biobank. Main outcome measures: First incident pneumonia over an average of 8 follow-up years. Results: 107,310 (30%) participants had hypertension at UK Biobank enrolment, and 9,969 (3%) developed a pneumonia during follow-up. Prevalent hypertension at baseline was significantly associated with increased risk for incident respiratory disease including pneumonia (hazard ratio 1.36 (95% confidence interval 1.29 to 1.43), P<0.001), acute respiratory distress syndrome or respiratory failure (1.43 (1.29 to 1.59), P<0.001), and chronic lower respiratory disease (1.30 (1.25 to 1.36), P<0.001), independent of age, age2, sex, smoking status, BMI, prevalent diabetes mellitus, prevalent coronary artery disease, and principal components of ancestry. Mendelian randomisation analyses indicated that genetic predisposition to a 5 mmHg increase in blood pressure was associated with increased risk of incident pneumonia for SBP (1.08, (1.04 to 1.13), P<0.001) and DBP (1.11 (1.03 to 1.20), P=0.005). Additionally, consistent with epidemiologic associations, increase in blood pressure genetic risk was significantly associated with reduced forced expiratory volume in the first second, forced vital capacity, and the ratio of the two (P<0.001 for all). Conclusions: These results strongly suggest that elevated blood pressure independently increases risk for pneumonia and reduces pulmonary function. Maintaining adequate blood pressure control, in addition to other measures, may reduce risk for pneumonia. Whether the present findings are generalizable to novel coronavirus disease 2019 (COVID-19) require further study.


2
Hypertension is a highly prevalent, modifiable risk factor for cardiovascular disease and 3 mortality 1 . Epidemiologic analyses have correlated hypertension with pneumonia risk in small 4 studies 2 3 . Whether this represents a direct consequence of hypertension or influence of co-5 morbid risk factors such as age, diabetes mellitus, air pollution, or smoking is unclear.

7
Hypertension has emerged as one of the most well-recognized risk factors for developing novel 8 coronavirus disease 2019 (COVID-19) from SARS-CoV-2 infection [4][5][6][7] . In particular, patients with 9 COVID-19 who develop acute respiratory distress syndrome (ARDS) are particularly enriched 10 for hypertension 7 . Angiotensin converting enzyme (ACE) is an endogenous regulator of blood 11 pressure that is highly expressed in the lung and has been linked to risk for acute respiratory 12 distress syndrome (ARDS) 8 9 . ACE2, a homolog and endogenous counter-regulator of ACE, is 13 expressed in a subset of type II alveolar cells and is an important facilitator of cell entry by 14 SARS-CoV-2 [8][9][10] . ACE2 has also been implicated in lung injury related to other respiratory 15 viruses and bacterial pathogens [11][12][13] . While professional societies have encouraged patients to 16 remain on ACE inhibitors during the present pandemic, recommendations were largely made in 17 the absence of robust human data.

19
Although epidemiologic analyses support a plausible causal relationship between blood 20 pressure regulation and respiratory infection risk, confounding from comorbid conditions limit 21 such inference. Importantly, comorbid factors such as advanced age, diabetes mellitus, and 22 cardiovascular disease have also been described as independent risk factors for pneumonia 23 previously as well as for COVID-19. Mendelian randomisation is a statistical approach using 24 genetic proxies for an exposure as opposed to the exposure itself to mitigate risks for 25 confounding facilitating more robust causal inference 14 . Blood pressure is a highly heritable trait 26 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org /10.1101/10. /2020 with several known associated genomic loci that may serve as a robust aggregated genetic 1 proxy for Mendelian randomization 15 .

3
In the UK Biobank prior to the COVID-19 pandemic, we (1) estimate the epidemiologic 4 association of hypertension with incident pneumonia risk and indices of pulmonary function, and

5
(2) apply Mendelian randomisation to test the hypothesis that blood pressure independently 6 causally influences risks for pneumonia and reduced pulmonary function.  British ancestry consenting to genetic analyses, with genotypic-phenotypic sex concordance, 20 without sex aneuploidy, and one from each pair of 1 st or 2 nd degree relatives selected randomly.

21
Participants provided informed consent as previously described. Secondary use of the data was

24
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020.  16 . Variants used in the 4 present analysis include those also imputed using the Haplotype Reference Consortium 5 reference panel of up to 39 million single nucleotide polymorphisms (SNPs) 17 18 . Poor quality 6 variants and genotypes were filtered as previously described 16

23
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org /10.1101/10. /2020 Patients taking at least one ACEi were included in the ACEi category, patients taking no ACEi 1 but at least one ARB were included in the ARB category, and patients who reported that they 2 were taking a blood pressure medication (via UK Biobank Field IDs 6153 and 6177) but were 3 not taking an ACEi or ARB were included in the 'other' category.        and accounting for skewness in the phenotypic data identified using the Robustbase package in 10 R (setting range=3) (https://cran.r-project.org/web/packages/robustbase/robustbase.pdf).

11
Phenotypes were then inverse rank normalized to mean 0 and standard deviation (SD) 1 for    CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org/10.1101/2020.04.19.20071936 doi: medRxiv preprint Genetic instruments for blood pressure and association analyses 1 One-sample Mendelian randomisation was performed in the UK Biobank by associating inverse-2 rank normalized systolic blood pressure and diastolic blood pressure polygenic risk scores (SBP

24
25 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020. Association analysis of the SBP and DBP PRS with incident respiratory diseases was 1 performed using Cox proportional hazards models in R (version 3.5, R Foundation, Vienna, 2 Austria), adjusting for age, age 2 , sex, smoking status, and the first ten principal components of 3 ancestry. The proportional hazards assumption was assessed by Schoenfeld residuals and was 4 satisfied. Association analyses between the SBP and DBP PRS and pulmonary function tests 5 was performed using a generalized linear model adjusted for the same covariates.

7
Association of the 75 variants for each PRS with both prevalent and incident pneumonia was 8 performed using a logistic regression Wald test in Hail-0.2, adjusting for age, age 2 , sex, smoking 9 status, the first ten principal components of ancestry, and genotype array. Using these 10 associations, two-sample Mendelian randomization was performed using the ICBP-derived SBP  CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020.

26
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020.   (Figure 2). However, upon further adjustment for prevalent hypertension status, we did not 7 observe an association of these medication classes with risk for pneumonia.

9
Genetic association of blood pressure with incident respiratory disease 10 11 We first used one-sample Mendelian randomisation to determine whether a genetic 12 predisposition to increased blood pressure is associated with increased risk for incident 13 pneumonia as well as other respiratory diseases.

26
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

3
Each SD increase in the SBP PRS was associated with a significant increased risk of incident

25
suggesting that no single SNP drives the observed association (Supplementary Figure 1).

26
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020.

23
In a large, prospective, population-based cohort, we show that prevalent hypertension is a risk 24 factor for incident pneumonia, lower respiratory infections, ARDS or respiratory failure, as well 25 as many other respiratory diseases. Additionally, our epidemiological analyses also 26 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020. . demonstrate an association between prevalent hypertension and increased pulmonary 1 obstruction as indicated by reduced FEV1/FVC. Our Mendelian randomisation studies imply that 2 the relationship between increased blood pressure with increased risk for pneumonia as well as 3 reduced pulmonary function may be causal.     ACEi may be protective for pneumonia risk 42 . As detailed earlier, since ACE2 may serve as a 25 receptor for respiratory viral entry and is an endogenous counter-regulator of ACE, conflicting 26 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020.

11
Thus, withdrawal of ACEi and challenges of blood pressure management while promoting 12 physical distancing, may not only have untoward cardiovascular consequences but may 13 inadvertently increase pneumonia risk.

15
Strengths and limitations 16 17 This study has several strengths, including the analysis of a large, genotyped population-based 18 cohort with high fidelity phenotyping, including with subclinical respiratory phenotypes.

19
Furthermore, diverse phenotyping facilitates extensive individual-level covariate adjustment in 20 the models and sensitivity analyses to assess for pleiotropy. Our overall study design, with the CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org/10.1101/2020.04.19.20071936 doi: medRxiv preprint association of the genetic instrument to the outcome occurs via the primary exposure and is not 1 confounded by pleiotropy 50 51 . We have performed a number of sensitivity analyses to assess for 2 possible confounders, in particular, we observe that our genetic instruments for blood pressure 3 are not associated with key socioeconomic and lifestyle factors influencing both blood pressure 4 and pneumonia risk. We further maintain a sparsely adjusted model in our one-sample 5 Mendelian randomization analyses to reduce the potential for collider bias 52

19
Our study provides evidence that hypertension directly influences the risk of pneumonia.

20
Vigilance for blood pressure monitoring and management may reduce risk for pneumonia,

22
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020.

13
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020.   . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020.      . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020. .  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org/10.1101/2020.04.19.20071936 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org/10.1101/2020.04.19.20071936 doi: medRxiv preprint